Recall Register

Food, drugs, devices › PharMEDium Services, LLC

Drug recall: ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL, In 0.9% Sodium Chloride 10 mL syringe, For IV Use Preservative Free Pha

FDA enforcement event 85212 · Class II · initiated 16 Mar 2020 · status Terminated · terminated 14 Feb 2025

DrugVoluntary: Firm initiated13 product recordsDayton, NJ

FDA enforcement event 85212 is a drug recall by PharMEDium Services, LLC of Dayton, NJ, initiated 16 Mar 2020 and classified Class II, with 13 product records.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 64% of the 342 drug enforcement events initiated in 2020 carry the same class.

Status: Terminated, terminated 14 Feb 2025. Initiation: voluntary: firm initiated. PharMEDium Services, LLC has 30 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

PharMEDium Services, LLC, Dayton, NJ.

Reason for recall

"Firm is recalling 46 lots of various products because of a lack of sterility assurance."

Distribution

"Distributed Nationwide in the US"

Product records

Recall numberProductQuantityClassStatusReport date
D-1081-2020ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL, In 0.9% Sodium Chloride 10 mL syringe, For IV Use Preservative Free PharMEDium 913 N. Davis Ave. Cleveland, MS NDC 71030-003-121075 unitsClass IITerminated15 Apr 2020
D-1082-2020nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9% Sodium Chloride Injection USP, 10 ml in a 20mL syringe, Rx Only, PharMEDium Services LLC 12620 W. Airport Boulevard #130 Sugar Land, TX 77470. NDC 71019-206-0180 unitsClass IITerminated15 Apr 2020
D-1083-2020rocuronium Bromide 10 mg per mL 50 mg per 5 mL, 5 mL BD Syringe, For IV Use, PharMEDium 913 N. Davis Ave. Cleveland, MS. Preservative Free, NDC 71019-321-104625 unitsClass IITerminated15 Apr 2020
D-1084-2020HYDROmorphone in 0.9% Sodium Chloride HCl, 1 mg per mL, For IV Use, 30 mg per 30 mL, 30 mL in a 35 mL Monoject Barrel Syringe, PharMEDium Services LLC 913 M. Davis Ave Cleveland, MS. NDC 61553-166-441840 unitsClass IITerminated15 Apr 2020
D-1085-2020fentaNYL Citrate 10 mcg per mL, 2,500 mcg per 250 mL, 250 mL in a LifeCare Bag, in Sodium Chloride 0.9%. Rx Only, PharMEDium Services, LLC 913 N. Davis Ave Cleveland, MS 36732 NDC 61553-113-50210 unitsClass IITerminated15 Apr 2020
D-1086-2020succinylcholine Chloride, 20 mg per 5 mL, 100 mg per 5 mL, 5 mL BD Syringe, For IV Use, PharMEDium 913 N. Davis Ave, Cleveland, MS. NDC 71019-341-042475 unitsClass IITerminated15 Apr 2020
D-1087-2020rocuronium Bromide, 10 mg per mL, 50 mg per 5 mL, 5 mL BD Syringe, for IV Use, PharMEDium 13N. Davis Ave. Cleveland MS 36732. NDC 71019-321-052250 unitsClass IITerminated15 Apr 2020
D-1088-2020ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL in 0.9% Sodium Chloride, 5 mL syringe, For IV use, Preservative Free, PharMEDium 913 W Davis Ave Cleveland MS 38732 NDC 71030-003-09375 unitsClass IITerminated15 Apr 2020
D-1089-2020fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500 mcg per 30 mL, 30 mL Total Volume, in a 35 mL Monoject Barrel Syringe, PharMEDium Services, LLC 913 N. Davis Avenue Cleveland, MS 38732. NDC 61553-672-44290 unitsClass IITerminated15 Apr 2020
D-1090-2020ePHEDrine Sulfate 5 mg per mL 25 mg per 5 mL, in 0.9% Sodium Chloride, 5 mL BD Syringe, For IV Use, Rx Only, PharMEDium 913 N. Davis Ave. Cleveland, MS 98732 NDC 71030-003-021500 unitsClass IITerminated15 Apr 2020
D-1091-2020ePHEDrine Sulfate 10 mg per mL 50 mg per 5 mL in 0.9% 5 mL Sodium Chloride 5 mL syringe, For IV Use, Rx Only, PharMEDium 913 N Davis Avenue Cleveland, MS NDC 71030-001-09900 unitsClass IITerminated15 Apr 2020
D-1092-2020fentaNYL Citrate Injection, 50 mcg per mL, 250 mcg per 5 mL 5 mL syringe, For IV Use, Rx Only, PharMEDium Services, LLC 36 Stutte Road Dayton, NJ. NDC 61553-306-3375 unitsClass IITerminated15 Apr 2020
D-1093-2020fentaNYL Citrate Injection 50 mcg per mL, 100 mcg per 2 mL, 2 mL per syringe, For IV Use, Rx Only, PharMEDium Services, LLC 913 N. Davis Ave Cleveland, MS 05810. NDC 61553-303-281350 unitsClass IITerminated15 Apr 2020

Context

64%of 2020 drug events are Class II342 events that year
13product records in this eventfirm median: 2
30events on this register for the firm

Other enforcement events for PharMEDium Services, LLC

InitiatedProduct (first record)TypeClassRecords
16 Dec 2019NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00 mL Viaflex DrugClass III3
7 Jun 2019Hydromorphone HCl in 0.9% sodium chloride, 0.5mg per mL, 1 mL in 3mL BD Syringe, PharMEDium 913 N Davis Ave Cleveland, MDrugClass I1
2 Jan 20190.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% BDrugClass II1
5 Dec 2018Fentanyl Citrate 2 mcg per mL (100 mcg per 50 mL) and Ropivacaine HCl 0.1% in Sodium Chloride 0.9%, Injection, 50 mL totDrugClass II2
24 Jul 201810 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 250 mL in 250 mL Intravia Bag and 10 mcg/mL FentaDrugClass II3
5 Jun 2018HYDROmorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride, 1 mL Total Volume in 3 mL syringe, Rx, PharMEDium Services, LLCDrugClass II1
10 Apr 2018Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USP (0.2 units per mL), Rx only, PharMEDium ServicesDrugClass III1
5 Feb 201815 units Oxytocin added to 0.9% Sodium Chloride Injection, 250 mL Viaflex Bag, Rx only, PharMEDium Serivces, LLCDrugClass II3
27 Dec 2017HYDROmorphone HCl in Sodium Chloride 0.9% in all doses, all strengths, and all packaging.DrugClass II42
30 Oct 2017ePHEDrine Sulfate In 0.9% Sodium Chloride, 5 mg per mL (50 mg per 10 mL), 10 mL Total Volume pre-filled syringes, packagDrugClass II1

All 30 events for PharMEDium Services, LLC

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Firm is recalling 46 lots of various products because of a lack of sterility assurance."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Distributed Nationwide in the US"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 14 Feb 2025. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.